|
|
|
Program > Program at a glance
|
Wednesday September, 25 |
||
|
16h00-17h00 |
Participants welcome and registration (Bias 2, Hall) |
|
|
18h00-19h30 |
Early career researcher group (Bias 2, Room 006) |
|
|
19h30 |
Welcome reception
Participants welcome and registration Little Atlantic Brewery |
|
|
|
|
|
|
Thursday September, 26 |
||
|
8h00-9h00 |
Participants welcome and registration (Bias 2, Hall) |
|
|
9h00-10h30 |
Opening session (Bias 1, Main amphi) |
Welcome opening speech: Pascal Marchand (Nantes Université), Pierre Caillault (Nantes Métropole), Jean-Pascal Fournier (organizing committee) Opening keynote: Dealing with polypharmacy - Lessons learned from 25 years of deprescribing (Barbara Farrell) |
|
10h30-11h00 |
Break |
|
|
11h00-12h30 |
Plenary Oral communications #1 (Bias 1, Main amphi) |
Impact of Deprescribing Initiatives, Guidelines and Policies From Around the World |
|
12h30- 14h00 |
Lunch (Bias 1, Hall) |
|
|
14h00-15h30 |
Parallel sessions |
|
|
|
Oral communications #2 (Bias 1, Main amphi) |
Central Nervous System Active Medications: Opportunities for Deprescribing |
|
|
Workshops |
|
|
|
(Bias 2, Room 004) |
W1- Deprescribing Research: A Workshop Addressing Study Design, Measurement, and Implementation Challenges in Primary Care (Cynthia Boyd, Michael Steinman, Sandra Simmons) |
|
|
(Bias 2, Room 005) |
W2- Deprescribing Communication: Global summary and Application Opportunities (Robert Wahler, Na Ouyang, Danijela Gnjidic, Marcia Mecca, Ariel Green, Sarah Hilmer, Holly Holmes, Emily Reeve, Nancy Schoenborn, Ranjit Singh, Richard Street, Carmen Reyes, Sandra Ko, Terri Fried) |
|
|
(Bias 2, Room 006) |
W3- Integrating Deprescribing Competencies into Health Care Curricula: A “How To” Workshop (Barbara Farrell, Lalitha Raman-Wilms, Cheryl Sadowski, Emily G. McDonald) |
|
15h30-16h30 |
Break – Poster session (Bias 1, Hall) |
|
|
16h30- 17h30 |
First day closing keynote (Bias 1, Main amphi) |
First day closing keynote: Transforming insomnia care with a direct-to-patient mailed sedative deprescribing intervention (Georges Marcoux - David Gardner) |
|
17h30-18h00 |
Departure of participants |
|
|
20h00 |
Conference dinner O'Deck restaurant |
|
|
Friday September 27 |
||
|
8h00-9h00 |
Participants welcome |
|
|
9h00-10h30 |
Parallel sessions |
|
|
|
Oral communications #3 (Bias 1, Main amphi) |
Deprescribing in the Real World: Learnings from Pharmacoepidemiology, Implementation Science, and Framework Development |
|
|
Workshops |
|
|
|
(Bias 2, Room 004) |
W4- Developing and implementing team-based deprescribing actions at the institutional level (Damien Cateau, Florent Mace, Anne Niquille) |
|
|
(Bias 2, Room 005) |
W5- Inappropriate prescribing cascades: Identifying and deprescribing the domino effect (Kieran Dalton, Fatma Karapinar, Lisa McCarthy) |
|
|
(Bias 2, Room 006) |
W6- Deprescribed or discontinued? A lexical question that makes a significant difference for research and clinical practice (Caroline Sirois, Alexandre Campeau Calfat, Emily Reeve, Cynthia Boyd, Justin Turner) |
|
10h30-11h15 |
Break – Poster session (Bias 1 hall) |
|
|
11h15-12h45 |
Parallel sessions |
|
|
|
Oral communications #4 (Bias 1, Main amphi) |
Technology and medication review to support deprescribing |
|
|
French Symposium (Bias 2, Room 004) |
|
|
|
Workshops |
|
|
|
(Bias 2, Room 005) |
W7- Deprescribing long-term use of antidepressants: strategies for clinical practice (Ellen Van Leeuwen, Jacqueline Hugtenburg, Hanne Creupelandt, Joke Pauwelyn, Hanna Bowers, Catherine Woods, Tony Kendrick, Thierry Christiaens). |
|
|
(Bias 2, Room 006) |
W8- The role of the private sector in deprescribing: What role should pharmaceutical and biotechnology companies play? (Katharina Tabea Jungo, Cynthia Boyd, Caroline McCarthy, Barbara Farrell) |
|
|
(Bias 2, Room 007) |
W9- Innovations and challenges in deprescribing opioids in older people (Gert Baas, Sanne Bakker-Verdoorn, Henk-Frans Kwint) |
|
12h45-13h45 |
Lunch (Bias 1, Hall) |
|
|
13h45-15h15 |
Parallel sessions |
|
|
|
Oral communications #5 (Bias 1, Main amphi) |
Updates in Measurement Relevant to Deprescribing Evaluations |
|
|
Workshops |
|
|
|
(Bias 2, Room 004) |
W10- Global Workshop on Engaging Stakeholders in Deprescribing and Age Friendly 4Ms Care (Nicole Brandt, Robert Wahler, Daniel Mansour, Jennifer Stoll, Catherine Sarkisian, Carmen Reyes, Suvi Hakoinen, Marja S Airaksinen, Mustafa Awad) |
|
|
(Bias 2, Room 005) |
W11- Economic evaluations of deprescribing interventions (Caroline McCarthy, Frank Moriarty) |
|
|
(Bias 2, Room 006) |
W12- Finding the Sweet Spot: Choosing Glycemic Control Wisely for Older Adults with Diabetes (Wade Thompson, Iliana Lega, Lisa McCarthy) |
|
|
(Bias 2, Room 007) |
|
|
15h15-15h30 |
Break |
|
|
15h30-17h00 |
Original communications #6 (Bias 1, Main amphi) |
Evaluations of Deprescribing Interventions Around the Globe |
|
17h00-18h00 |
Closing session (Bias 1, Main amphi) |
Closing speech Closing keynote: Looking back and looking forward - Where to next for deprescribing? (Anne Spinewine, Franck Moriarty) |
|
18h00-18h30 |
Departure of participants |
|
W13- Développer et mettre en œuvre des activités interprofessionnelles de déprescription au niveau d'une institution (Damien Cateau, Florent Mace, Anne Niquille) (session en français)
| Online user: 2 | Privacy |
|
